Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
Conclusion: Overexpression of TROP2 in endometrioid-type endometrial carcinoma seems to be a poor prognostic factor; it may be useful in determining the biologically more aggressive tumors before the treatment. This early determination is very important to choose the appropriate surgery, adjuvant-treatments, and follow-up.
PMID: 32769331 [PubMed - in process]
Source: Indian Journal of Pathology and Microbiology - Category: Pathology Authors: Celik SY, Çelik Öİ Tags: Indian J Pathol Microbiol Source Type: research
More News: Cancer & Oncology | Carcinoma | Endometrial Cancer | Hysterectomy | India Health | Microbiology | Pathology | Statistics | Study